OTCMKTS:CLPBF Coloplast A/S (CLPBF) Stock Price, News & Analysis $62.81 0.00 (0.00%) As of 09/22/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Coloplast A/S Stock (OTCMKTS:CLPBF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Coloplast A/S alerts:Sign Up Key Stats Today's Range$62.81▼$62.8150-Day Range$60.06▼$68.3352-Week Range$56.81▼$95.43VolumeN/AAverage Volume1,581 shsMarket CapitalizationN/AP/E Ratio5.50Dividend Yield11.94%Price TargetN/AConsensus RatingN/A Company Overview Coloplast A/S is a Denmark-based medical technology company that develops products and services for people with intimate and personal healthcare needs. Its portfolio is focused on improving quality of life and supporting healthcare professionals in the treatment of chronic conditions. The company’s main business areas include ostomy care, continence care, wound and skin care, and interventional urology. Its products include ostomy bags and accessories, catheters for bladder management, continence-care solutions, wound-care products, and devices used in urological procedures. Coloplast also provides education, support, and related services for patients and healthcare providers. Coloplast traces its origins to 1957, when nurse Elise Sørensen developed an adhesive ostomy bag after her sister underwent an ostomy operation. The company is headquartered in Humlebæk, Denmark, and serves customers through operations and distribution networks across numerous international markets. Kristian Villumsen has served as the company’s president and chief executive officer.AI Generated. May Contain Errors. Read More Coloplast A/S Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreCLPBF MarketRank™: Coloplast A/S scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Coloplast A/S. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Coloplast A/S is 5.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.64.Price to Earnings Ratio vs. SectorThe P/E ratio of Coloplast A/S is 5.50, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.40.Read more about Coloplast A/S's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverColoplast A/S has a short interest ratio ("days to cover") of 329.38, which indicates bearish sentiment.Change versus previous monthShort interest in Coloplast A/S has recently increased by 7.96%, indicating that investor sentiment is decreasing significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldColoplast A/S pays a meaningful dividend of 1.54%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthColoplast A/S does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Coloplast A/S is 65.69%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Coloplast A/S's dividend. News and Social Media2.9 / 5News SentimentN/A News SentimentColoplast A/S has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Coloplast A/S this week, compared to 0 articles on an average week. Company Ownership0.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Coloplast A/S insiders have not sold or bought any company stock.Percentage Held by Institutions15.14% of the stock of Coloplast A/S is held by institutions.Read more about Coloplast A/S's insider trading history. Receive CLPBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLPBF Stock News HeadlinesColoplast A/S - Financial Calendar 2026/27September 24 at 9:31 AM | marketscreener.comMSupporting the continued long-term and stable ownership of ColoplastSeptember 4, 2026 | uk.finance.yahoo.comTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.September 24 at 1:00 AM | Behind the Markets (Ad)Coloplast A/S Non-GAAP EPS of DKK 6.55, revenue of DKK 7.26B; reaffirms FY 2026 outlookAugust 19, 2026 | seekingalpha.comColoplast A/S - Interim Financial Report, 9M 2025/26August 18, 2026 | finance.yahoo.comColoplast expects Kerecis wound-care unit to return to growth in 2027, CFO saysAugust 18, 2026 | msn.comColoplast A/S - Announcement no. 6/2026 - Coloplast announces changes to Executive Leadership TeamAugust 17, 2026 | finance.yahoo.comColoplast Might Have Found Its BottomAugust 5, 2026 | seekingalpha.comSee More Headlines CLPBF Stock Analysis - Frequently Asked Questions How have CLPBF shares performed this year? Coloplast A/S's stock was trading at $83.70 at the beginning of the year. Since then, CLPBF stock has decreased by 25.0% and is now trading at $62.81. How do I buy shares of Coloplast A/S? Shares of CLPBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/24/2026Next Earnings (Estimated)11/03/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:CLPBF CIK1294325 Webwww.coloplast.com Phone(454) 911-1111FaxN/AEmployees15,930Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio5.50 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:CLPBF) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredNASA's ISS Replacement Could Go to This Tiny Space FirmNASA has commissioned SpaceX to decommission the $150 billion International Space Station, but the contract to...Behind the Markets | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coloplast A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Coloplast A/S With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
